(Q50956245)

26 March 2018

title

Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine? (English)

1 reference

26 March 2018

1 reference

Zanetti A

1

1 reference

26 March 2018

Pregliasco F

2

1 reference

26 March 2018

Andreassi A

3

1 reference

26 March 2018

Pozzi A

4

1 reference

26 March 2018

Viganò P

5

1 reference

26 March 2018

Cargnel A

6

1 reference

26 March 2018

Briantais P

7

1 reference

26 March 2018

Vidor E

8

1 reference

26 March 2018

publication date

1 January 1997

1 reference

26 March 2018

published in

Journal of Hepatology

1 reference

26 March 2018

volume

26

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

25-30

1 reference

26 March 2018

Frequency of illness associated with epidemic hepatitis A virus infections in adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Preparation and immunogenicity of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Interruption of an outbreak of hepatitis A in two villages by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Simultaneous passive and active immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Seroepidemiological investigation of patients and family contacts in an epidemic of hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Sensitive assays for hepatitis A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Does tetanus immune globulin interfere with the immune response to simultaneous administration of tetanus-diphtheria vaccine? A comparative clinical trial in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Simultaneous passive and active immunization against hepatitis B: noninterference of hepatitis B immune globulin with the anti-HBs response to reduced doses of heat-inactivated hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

Specific suppression of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980005-0

7 January 2021

10.1016/S0168-8278(97)80005-0

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018